What is the appropriate treatment plan for a 74-year-old male with a history of non‑ST‑elevation myocardial infarction and percutaneous coronary intervention who is experiencing runs of ventricular tachycardia while awake?

Treatment Plan for Awake Runs of VT in 74yo Post-NSTEMI/PCI Patient

This patient requires immediate IV beta-blocker therapy as first-line treatment, urgent assessment for recurrent ischemia with consideration for repeat coronary angiography, correction of any electrolyte abnormalities, and if VT episodes are frequent or refractory, IV amiodarone should be initiated. 1

Immediate Management Algorithm

1. Assess Hemodynamic Stability First

• If hemodynamically unstable (hypotension <90 mmHg systolic, pulmonary edema, ongoing chest pain):

  • Proceed directly to synchronized cardioversion 2, 3
  • Brief anesthesia/conscious sedation if time permits

• If hemodynamically stable (which appears to be your case since patient is awake):

  • Proceed with medical management as outlined below

2. First-Line Pharmacologic Therapy

Beta-blockers are the cornerstone and should be started immediately unless contraindicated 4, 1. This is the most important initial intervention for preventing recurrent VT in the post-MI setting.

• IV metoprolol: 2.5-5.0 mg every 2-5 minutes up to 15 mg total over 10-15 minutes 2, 3
• Monitor heart rate and blood pressure continuously
• Hold if systolic BP <100 mmHg or HR <50 bpm

3. Rule Out Recurrent Ischemia - CRITICAL STEP

Recurrent or persistent VT in a post-NSTEMI patient strongly suggests ongoing ischemia or incomplete revascularization 1. This is a common pitfall—treating the arrhythmia without addressing the underlying cause.

• Obtain immediate 12-lead ECG looking for new ST-segment changes
• Check troponin levels
• Strongly consider urgent coronary angiography to assess:
  • Stent patency/thrombosis
  • Progression of disease in non-stented vessels
  • Chronic total occlusions that may be contributing 5

The 2015 ESC guidelines explicitly state: "Recurrent sustained VT, especially when polymorphic, or recurrent VF may be an indicator of incomplete reperfusion or recurrence of acute ischemia. Immediate coronary angiography should therefore be considered" 1

4. Correct Metabolic Abnormalities

Check and aggressively correct 1:

• Potassium: Target >4.0-4.5 mEq/L
• Magnesium: Target >2.0 mg/dL (give 2g IV magnesium sulfate empirically if low or borderline)
• Acid-base status
• Oxygenation

5. Antiarrhythmic Drug Therapy

Only if VT episodes are frequent and cannot be controlled by beta-blockers alone 1:

Amiodarone is the preferred agent:

• Loading: 150 mg IV over 10 minutes 2, 1
• May repeat 150 mg if VT recurs
• Maintenance infusion: 1 mg/min for 6 hours, then 0.5 mg/min for 18 hours
• Transition to oral: 400 mg every 8-12 hours for 1-2 weeks, then 200-400 mg daily 6

Lidocaine is an alternative if amiodarone is contraindicated or unavailable 1:

• Bolus: 1.0-1.5 mg/kg IV 2, 4
• Additional boluses of 0.5-0.75 mg/kg every 5-10 minutes up to 3 mg/kg total
• Maintenance: 2-4 mg/min infusion

Important caveat: The 2015 ESC guidelines note that "intravenous lidocaine may be considered for recurrent sustained VT or VF not responding to beta-blockers or amiodarone" 1, making it a second-line option.

6. Consider Catheter Ablation

If VT is refractory to medical therapy (recurrent despite beta-blockers and amiodarone):

• Radiofrequency catheter ablation should be considered at a specialized center 1
• This is particularly effective for VT triggered by PVCs from partially injured Purkinje fibers in the post-MI setting 1
• Can be performed urgently even in the acute phase

7. Long-Term Management Considerations

• Continue oral beta-blocker therapy indefinitely 1
• ICD evaluation: If LVEF ≤35% at least 40 days post-MI and 90 days post-revascularization, ICD is indicated for primary prevention 3
• For this patient with recurrent VT while awake, ICD is likely indicated regardless of EF for secondary prevention
• Prophylactic antiarrhythmic drugs (other than beta-blockers) are NOT recommended and may be harmful 1

Critical Pitfalls to Avoid

1. Don't treat the arrhythmia without looking for ischemia: The most common mistake is focusing solely on rhythm control while missing acute stent thrombosis or progression of CAD 1, 5

2. Don't use multiple antiarrhythmic drugs simultaneously: Stick to beta-blockers first, add amiodarone only if needed. Combining agents increases proarrhythmic risk 7

3. Don't delay angiography: If VT persists or recurs despite initial therapy, this patient needs the cath lab, not more medications

4. Don't forget electrolytes: Hypokalemia and hypomagnesemia are easily correctable triggers that are frequently overlooked 2, 1

5. Avoid procainamide, flecainide, and other Class I agents in this post-MI patient—they increase mortality in ischemic heart disease 6